Spun out of the Goluch Group at Northeastern University, Boston, MA., QSM Diagnostics, the principals of the firm bring several decades of experience in the development and commercialization of medical devices with particular expertise in sensor development. The firm is organized around developing a point-of-care diagnostics for identification of bacterial infections with the firm's initial product being designed for assisting in the determination of urinary tract infection in human and animal samples. Tests for other infectious diseases are in development. Multiple patents pending in the areas of electrochemical sensing will allow development of the means to detect target molecules faster, more reliably, using a one-step method. The firm's tests can be performed directly in any biological fluid with zero sample preparation or incubation. The systems electrochemical output allows use of a battery powered handheld reader to obtain the test results in minutes. The capability also exists to detect and quantify multiple biomarkers simultaneously in a single test. With the focus currently on rapid tests for medical and healthcare applications, QSM Diagnostics's first product is a dog ear infection sensor that will be available for purchase soon.